JQAD1 is a CRBN-dependent PROTAC designed to selectively degrade EP300. By targeting EP300, it reduces its expression and diminishes the H3K27ac modification, leading to apoptosis. This compound serves as a valuable tool for studying related biological processes.
Usually ships within 24 hours.